 | • レポートコード：MRC2304E041 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、236ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社発行の当調査レポートでは、2021年に1,291.24百万ドルであった世界のマイクロRNA市場規模が、2022年に1,654.98百万ドルに達し、2027年には5,793.00百万ドルまで年平均28.42%で成長すると予測しています。当レポートは、マイクロRNAの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、アッセイ種類別（化学発光アッセイ、比色アッセイ、蛍光アッセイ、免疫アッセイ、その他）分析、製品別（医療消耗品、医療器具）分析、サービス種類別（機能研究、マイクロアレイ）分析、用途別（がん、心血管疾患、免疫疾患、感染症、神経疾患）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でまとめています。なお、当書には、Agilent Technologies, Inc.、Bio-Rad Laboratories Inc.、BioDynamics Laboratory Inc.、BioGenex Inc.、GeneCopoeia, Inc.、Horizon Discovery Ltd.、HTG Molecular Diagnostics, Inc.、Illumina, Inc.、Merck KGaA、Miltenyi Biotec Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のマイクロRNA市場規模：アッセイ種類別 - 化学発光アッセイの市場規模 - 比色アッセイの市場規模 - 蛍光アッセイの市場規模 - 免疫アッセイの市場規模 - その他アッセイ種類の市場規模 ・世界のマイクロRNA市場規模：製品別 - 医療消耗品の市場規模 - 医療器具の市場規模 ・世界のマイクロRNA市場規模：サービス種類別 - 機能研究の市場規模 - マイクロアレイの市場規模 ・世界のマイクロRNA市場規模：用途別 - がんにおける市場規模 - 心血管疾患における市場規模 - 免疫疾患における市場規模 - 感染症における市場規模 - その他用途における市場規模 ・世界のマイクロRNA市場規模：地域別 - 南北アメリカのマイクロRNA市場規模 アメリカのマイクロRNA市場規模 カナダのマイクロRNA市場規模 ブラジルのマイクロRNA市場規模 … - アジア太平洋のマイクロRNA市場規模 日本のマイクロRNA市場規模 中国のマイクロRNA市場規模 インドのマイクロRNA市場規模 韓国のマイクロRNA市場規模 台湾のマイクロRNA市場規模 … - ヨーロッパ/中東/アフリカのマイクロRNA市場規模 イギリスのマイクロRNA市場規模 ドイツのマイクロRNA市場規模 フランスのマイクロRNA市場規模 ロシアのマイクロRNA市場規模 … - その他地域のマイクロRNA市場規模 ・競争状況 ・企業情報 |
The Global microRNA Market size was estimated at USD 1,291.24 million in 2021 and expected to reach USD 1,654.98 million in 2022, and is projected to grow at a CAGR 28.42% to reach USD 5,793.00 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the microRNA to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Assay Type, the market was studied across Chemiluminescent Assays, Colorimetric Assays, Fluorescent Assays, Immunoassay, miRNA Arrays, Next-Generation Sequencing (NGS), and PCR-based Assay.
Based on Product, the market was studied across Consumables and Instruments.
Based on Services Type, the market was studied across Functional Studies Services and Microarray Services.
Based on Application, the market was studied across Cancer, Cardiovascular Disease, Immunological Disorder, Infectious Diseases, and Neurological Diseases.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for microRNA market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the microRNA Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global microRNA Market, including Agilent Technologies, Inc., Bio-Rad Laboratories Inc., BioDynamics Laboratory Inc., BioGenex Inc., GeneCopoeia, Inc., Horizon Discovery Ltd., HTG Molecular Diagnostics, Inc., Illumina, Inc., Merck KGaA, Miltenyi Biotec Inc., NanoString Technologies, Inc., New England Biolabs, Inc., OriGene Technologies Inc., QIAGEN N.V., Quantabio Inc., SeqMatic LLC, Sistemic Scotland Limited, Synlogic Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global microRNA Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global microRNA Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global microRNA Market?
4. What is the competitive strategic window for opportunities in the Global microRNA Market?
5. What are the technology trends and regulatory frameworks in the Global microRNA Market?
6. What is the market share of the leading vendors in the Global microRNA Market?
7. What modes and strategic moves are considered suitable for entering the Global microRNA Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of chronic diseases and rising number of cancer cases
5.1.1.2. Growing importance of microRNA for the diagnosis of several diseases
5.1.1.3. Increasing research activities exploring the potential of microRNA globally
5.1.2. Restraints
5.1.2.1. High cost associated with microRNA kits and other products
5.1.3. Opportunities
5.1.3.1. Emerging microRNA tools for disease-associated analytical applications
5.1.3.2. Advancement in genomic studies and adoption of new tools for supporting research endeavors
5.1.4. Challenges
5.1.4.1. Safety and toxicity issues of microRNA
5.2. Cumulative Impact of COVID-19
6. microRNA Market, by Assay Type
6.1. Introduction
6.2. Chemiluminescent Assays
6.3. Colorimetric Assays
6.4. Fluorescent Assays
6.5. Immunoassay
6.6. miRNA Arrays
6.7. Next-Generation Sequencing (NGS)
6.8. PCR-based Assay
7. microRNA Market, by Product
7.1. Introduction
7.2. Consumables
7.3. Instruments
8. microRNA Market, by Services Type
8.1. Introduction
8.2. Functional Studies Services
8.3. Microarray Services
9. microRNA Market, by Application
9.1. Introduction
9.2. Cancer
9.3. Cardiovascular Disease
9.4. Immunological Disorder
9.5. Infectious Diseases
9.6. Neurological Diseases
10. Americas microRNA Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific microRNA Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa microRNA Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Bio-Rad Laboratories Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. BioDynamics Laboratory Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. BioGenex Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. GeneCopoeia, Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Horizon Discovery Ltd.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. HTG Molecular Diagnostics, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Illumina, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Merck KGaA
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Miltenyi Biotec Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. NanoString Technologies, Inc.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. New England Biolabs, Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. OriGene Technologies Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. QIAGEN N.V.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Quantabio Inc.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. SeqMatic LLC
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Sistemic Scotland Limited
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Synlogic Inc.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Takara Bio Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Thermo Fisher Scientific Inc.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing